Connection

David Taber to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications David Taber has written about Cost-Benefit Analysis.
David Taber
Connection Strength
0.120
Cost-Benefit Analysis
  1. Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation. J Pharm Pract. 2016 Apr; 29(2):97-102.
    View in: PubMed
    Score: 0.098
  2. Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes. Pharmacotherapy. 2013 May; 33(5):483-8.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.